During the past decade, Jian Xiao conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jian Xiao" are "Gastric Cancer" (2 trials), "Bone Marrow Metastasis" (1 trials) and "Disseminated Intravascular Coagulation" (1 trials). Many other conditions were trialed in "Jian Xiao" in a lesser frequency.

Most popular intervention types in "Jian Xiao" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-fluorouracil" (1 trials), "5fluorouracil" (1 trials), "DOXOrubicin Liposome Injection" (1 trials), "Docetaxel" (1 trials) and "Irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jian Xiao" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jian Xiao". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jian Xiao, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jian Xiao, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".